Civil Lawsuits as an Indicator of Adverse Outcomes in Healthcare.


Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
30 08 2022
Historique:
received: 21 06 2022
revised: 14 08 2022
accepted: 25 08 2022
entrez: 9 9 2022
pubmed: 10 9 2022
medline: 14 9 2022
Statut: epublish

Résumé

The financial burden of adverse healthcare outcomes in Poland still remains unknown. The objective of the study was to estimate the cost of adverse healthcare outcomes in the Polish healthcare system. Cost calculation was performed on the basis of civil cases completed in Polish courts against doctors and healthcare entities. The research material consisted of 183 civil cases completed by a final judgment in 2011-2013. The case study was conducted in five out of forty-five district courts across the country. Out of 183 reviewed cases, 73 complaints ended up with favorable judgments (39.9%). The average value of the subject matter of the dispute was USD 78,675. The total expected value of lawsuits in the 183 reviewed cases was USD 11,299,020. The total amount awarded in 73 judgments from medical facilities to injured patients was USD 2,653,595, which on average means USD 36,351 per case. The average amount of awarded compensation was USD 33,317 per case. The average compensation amount in the analyzed cases was USD 11,724. The average one-time annuity for a patient was USD 11,788. The estimated costs of negative healthcare outcomes amounted to USD 8,000,000 per year.

Identifiants

pubmed: 36078499
pii: ijerph191710783
doi: 10.3390/ijerph191710783
pmc: PMC9518515
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

N Engl J Med. 1991 Feb 7;324(6):370-6
pubmed: 1987460
BMJ Open. 2016 Aug 30;6(8):e011644
pubmed: 27577585
N Engl J Med. 2006 May 11;354(19):2024-33
pubmed: 16687715
Health Aff (Millwood). 2011 Apr;30(4):596-603
pubmed: 21471478
Health Aff (Millwood). 2010 Sep;29(9):1569-77
pubmed: 20820010
Int J Qual Health Care. 2017 Feb 01;29(1):9-18
pubmed: 28003370
JAMA. 1992 May 13;267(18):2487-92
pubmed: 1573726
Med Care. 2013 May;51(5):430-6
pubmed: 23552438
Gac Sanit. 2014 Jan-Feb;28(1):48-54
pubmed: 24309522
Int J Surg. 2016 Nov;35:100-103
pubmed: 27664560
Value Health. 2013 Mar-Apr;16(2):305-10
pubmed: 23538182
CMAJ. 1997 Oct 1;157(7):940-1
pubmed: 9327807
Int J Qual Health Care. 2016 Feb;28(1):33-9
pubmed: 26573788
Inj Prev. 2011 Oct;17(5):291-6
pubmed: 21622932
Issue Brief (Commonw Fund). 2011 Jul;14:1-18
pubmed: 21770079
BMC Health Serv Res. 2016 Aug 05;16(a):357
pubmed: 27494991
Clin Orthop Relat Res. 2009 Feb;467(2):434-42
pubmed: 18985423

Auteurs

Marcin Mikos (M)

Department of Economic and System Analyses, National Institute of Public Health-NIH-National Research Institute, 00-791 Warsaw, Poland.

Jolanta Budzowska (J)

Budzowska, Fiutowski & Partners. Attorneys-at-Law, 31-041 Krakow, Poland.

Tomasz Banaś (T)

Department of Gynecology and Obstetrics, Jagiellonian University Medical College, 31-501 Cracow, Poland.
Department of Radiotherapy, Maria Sklodowska-Curie Institute-Oncology Centre, 31-115 Cracow, Poland.

Dorota Kiedik (D)

Department of Population Health, Division of Public Health, Wroclaw Medical University, 50-345 Wroclaw, Poland.

Katarzyna Sygit (K)

Faculty of Health Sciences, Calisia University, 62-800 Kalisz, Poland.

Elżbieta Cipora (E)

Medical Institute, Jan Grodek State University in Sanok, 38-500 Sanok, Poland.

Beata Karakiewicz (B)

Subdepartment of Social Medicine and Public Health, Department of Social Medicine, Pomeranian Medical University in Szczecin, 71-210 Szczecin, Poland.

Mateusz Kaczmarski (M)

Medical Institute, Jan Grodek State University in Sanok, 38-500 Sanok, Poland.

Izabela Gąska (I)

Medical Institute, Jan Grodek State University in Sanok, 38-500 Sanok, Poland.

Olga Partyka (O)

Department of Economic and System Analyses, National Institute of Public Health-NIH-National Research Institute, 00-791 Warsaw, Poland.
Department of Health Economics and Medical Law, Medical University of Warsaw, 01-445 Warsaw, Poland.

Monika Pajewska (M)

Department of Economic and System Analyses, National Institute of Public Health-NIH-National Research Institute, 00-791 Warsaw, Poland.

Jakub Świtalski (J)

Department of Health Economics and Medical Law, Medical University of Warsaw, 01-445 Warsaw, Poland.

Anna Badowska-Kozakiewicz (A)

Department of Cancer Prevention, Medical University of Warsaw, 02-091 Warsaw, Poland.

Andrzej Deptała (A)

Department of Cancer Prevention, Medical University of Warsaw, 02-091 Warsaw, Poland.

Anna Augustynowicz (A)

Department of Health Economics and Medical Law, Medical University of Warsaw, 01-445 Warsaw, Poland.
School of Public Health, Centre of Postgraduate Medical Education of Warsaw, 01-826 Warsaw, Poland.

Michał Waszkiewicz (M)

School of Public Health, Centre of Postgraduate Medical Education of Warsaw, 01-826 Warsaw, Poland.

Aleksandra Czerw (A)

Department of Economic and System Analyses, National Institute of Public Health-NIH-National Research Institute, 00-791 Warsaw, Poland.
Department of Health Economics and Medical Law, Medical University of Warsaw, 01-445 Warsaw, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH